Literature DB >> 3786415

An update on the penetration depth of 630 nm light in normal and malignant human brain tissue in vivo.

P J Muller, B C Wilson.   

Abstract

Entities:  

Mesh:

Year:  1986        PMID: 3786415     DOI: 10.1088/0031-9155/31/11/012

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


× No keyword cloud information.
  12 in total

1.  An indwelling brachytherapy balloon catheter: potential use as an intracranial light applicator for photodynamic therapy.

Authors:  H Hirschberg; S Madsen; K Lote; T Pham; B Tromberg
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids.

Authors:  Steen J Madsen; Chung-Ho Sun; Bruce J Tromberg; Henry Hirschberg
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

3.  Identification of regions of normal grey matter and white matter from pathologic glioblastoma and necrosis in frozen sections using Raman imaging.

Authors:  Rachel Kast; Gregory Auner; Sally Yurgelevic; Brandy Broadbent; Aditya Raghunathan; Laila M Poisson; Tom Mikkelsen; Mark L Rosenblum; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2015-09-10       Impact factor: 4.130

4.  Enhanced cytotoxic effects of 5-aminolevulinic acid-mediated photodynamic therapy by concurrent hyperthermia in glioma spheroids.

Authors:  Henry Hirschberg; Chung-Ho Sun; Bruce J Tromberg; Alvin T Yeh; Steen J Madsen
Journal:  J Neurooncol       Date:  2004-12       Impact factor: 4.130

5.  Encephalopsin: a novel mammalian extraretinal opsin discretely localized in the brain.

Authors:  S Blackshaw; S H Snyder
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

6.  Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.

Authors:  Ryo Hiramatsu; Shinji Kawabata; Hiroki Tanaka; Yoshinori Sakurai; Minoru Suzuki; Koji Ono; Shin-ichi Miyatake; Toshihiko Kuroiwa; Erhong Hao; M Graça H Vicente
Journal:  J Pharm Sci       Date:  2014-12-26       Impact factor: 3.534

7.  ALA- and ALA-ester-mediated photodynamic therapy of human glioma spheroids.

Authors:  Henry Hirschberg; Chung-Ho Sun; Bruce J Tromberg; Steen J Madsen
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

8.  F8-SIP mediated targeted photodynamic therapy leads to microvascular dysfunction and reduced glioma growth.

Authors:  G Acker; A Palumbo; D Neri; P Vajkoczy; M Czabanka
Journal:  J Neurooncol       Date:  2016-05-17       Impact factor: 4.130

9.  The effects of ultra low fluence rate single and repetitive photodynamic therapy on glioma spheroids.

Authors:  Marlon S Mathews; Even Angell-Petersen; Rogelio Sanchez; Chung-Ho Sun; Van Vo; Henry Hirschberg; Steen J Madsen
Journal:  Lasers Surg Med       Date:  2009-10       Impact factor: 4.025

10.  Motexafin gadolinium enhances the efficacy of aminolevulinic acid mediated-photodynamic therapy in human glioma spheroids.

Authors:  Steen J Madsen; Marlon S Mathews; Even Angell-Petersen; Chung-Ho Sun; Van Vo; Rogelio Sanchez; Henry Hirschberg
Journal:  J Neurooncol       Date:  2008-09-06       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.